Imbed Biosciences
PrivateLast Round
Strategic
Jan 27, 2026
Total Funding Raised
$33.19M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Imbed Biosciences is a medical device company that develops advanced synthetic therapies and antimicrobial wound matrices for the treatment of surgical wounds, burns, chronic ulcers, and soft-tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imbed Biosciences Comparables
Compare Imbed Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Engineered Tissue Solutions | 87% | |
| SweetBio | 83% | |
| Advamedica | 82% |
Imbed Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 27, 2026 | ||||
| Convertible Debt | Jan 8, 2024 | ||||
| Debt | Dec 14, 2023 | ||||
| Debt | May 17, 2023 | ||||
| Series B | Nov 11, 2021 | ||||
Grant | Oct 14, 2021 |
Key People
Founding team and executive leadership
Imbed Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| NIH RADx | Grant |
| WISC Partners | Series A, Seed |
| Formidable Asset Management | Series A |
| Medical Technology Enterprise Consortium | Grant |
| Pegasus Tech Ventures | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 93% MoM.
- Apr 1, 2026
Company has commercial products sold in the U.S. and overseas.
Imbed Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Imbed Biosciences's valuation, stock price, and market status.
Is Imbed Biosciences a public or private company?
Imbed Biosciences is a private company.
What is the current stock price of Imbed Biosciences?
Imbed Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Imbed Biosciences worth (valuation)?
Valuation information for Imbed Biosciences is not publicly available.
Can I buy Imbed Biosciences stock?
Imbed Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Imbed Biosciences's last funding round?
Imbed Biosciences's most recent funding round was Convertible Debt on January 8, 2024.
Who are the main investors in Imbed Biosciences?
Key investors in Imbed Biosciences include National Institute of Arthritis and Musculoskeletal and Skin Diseases, WISC Partners, Formidable Asset Management.
Will Imbed Biosciences IPO soon?
No public IPO plans have been announced for Imbed Biosciences.
How can I track Imbed Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Imbed Biosciences's secondary market activity and sign up for updates.